Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > Francine
View:
Post by boozehound3 on Mar 26, 2020 2:07pm

Francine

When I told you to take a hike   I didn't mean for good.  I was hoping you would come back with some more insider information for the bag holders
Comment by Francine01 on Mar 26, 2020 3:22pm
Hey boozer, I am doing well. I hope the same for you. Obviously, not the best time for any investor from Buffet to me and you. Amarin went from 25$ to 10$ and matinas from 2.50$ to 0,50$. The entire sector is not doing very well. I think around july the SP will be back on trace. Next week, i am expecting an update on the package to the FDA and a meeting date (Will be most likely a Skype or call ...more  
Comment by alanmar1 on Mar 28, 2020 10:48am
The reason for the placebo problem is known and the explanation has gone or will be sent to the FDA by Tuesdau march 31.Within 75 days the FDA will respond.Things could be looking up.Incidently some of Amerins share price problems are a legal challenge to their product.Incidently its looked for a while that corn starch was better than the Amerin product
Comment by Rosmorduc on Mar 28, 2020 5:23pm
Corn starch placebo on CAPRE study showed better results than Amarin's product. So there is something seriously screwed up. My bet is on CAPRE and Trilogy 2. Like I said, it will be the grand slam heard around the world!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities